At a glance
ClinicalIndex Comparison RecordN/ACompleted· 130 enrolled
Drug / intervention
Positive incentive +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Incentive Models on Testing Adherence for Women With Diabetes During Pregnancy
In Brief
A clinical study evaluating Positive incentive and Loss aversion for Diabetes in Pregnancy. Completed, enrolled 130 participants across 1 site.
Detailed Summary
Diabetes in pregnancy carries significant pregnancy specific risks and requires frequent glucose monitoring to reduce these risks. This project compares the effect of two incentive schemes on adherence rates of glucose testing in pregnancy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes in Pregnancy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMay 2016
First PostedNov 2017
Primary CompletionDec 2019
Study CompletionJun 2022
TodayJul 2026
First PostedNov 9, 2017
Enrollment StartMay 5, 2016
Primary CompletionDec 18, 2019
Study CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 8.6 years ago
Interventions
Positive incentivebehavioral
Compensation is paid for each glucose test completed
Loss aversionbehavioral
Fixed compensation is offered to patients and they can earn a range of compensation at the completion of pregnancy depending on overall glucose testing adherence